First treatment for advanced small bowel cancer
Part of Cancer clinical trials.
This trial tests a new combination of drugs as the first treatment for small bowel adenocarcinoma that has spread or can't be removed with surgery. It aims to see if this approach can help control the cancer and improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with small bowel adenocarcinoma (a type of cancer in the small intestine).
- Your cancer is either locally advanced (cannot be removed with surgery) or has spread to other parts of the body.
- You have not had any prior treatment for this stage of cancer (beyond surgery, if applicable).
- You are generally well enough to carry out daily activities (ECOG performance status 0, 1, or 2, with a stricter limit if you are over 70).
- Your blood test results show that your bone marrow, liver, and kidneys are working well enough to safely receive the study drugs.
- You are not pregnant, breastfeeding, or planning to become pregnant during the study; you agree to use effective contraception if applicable.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of chemotherapy drugs (NALIRIFOX) for people with advanced small bowel adenocarcinoma that cannot be surgically removed. It is for those who have not yet had treatment for their advanced cancer, except possibly one cycle of FOLFOX.
This trial tests two standard chemotherapy combinations (FOLFIRINOX and FOLFOX) in people with small bowel adenocarcinoma that cannot be removed by surgery or has spread. It aims to see which works better for people who haven't had chemotherapy before.
This trial tests a combination of two chemotherapy drugs, levozolinate and 5-FU, given together as a first treatment for advanced colorectal cancer that cannot be surgically removed. It aims to see if giving them at the same time works better for patients who have never received treatment for this stage of cancer.
This trial studies a more customized treatment plan for people with locally advanced rectal (bowel) cancer after they receive FOLFIRINOX chemotherapy. It aims to reduce tumor spread risk and improve outcomes by tailoring the next steps based on scan details and your health status.
This Phase 2 study tests chemotherapy given before surgery (called FOLFIRINOX) for people with locally advanced stomach cancer. The goal is to shrink the tumor and improve outcomes after the surgery plan is completed.
This trial tests a stronger version of FOLFIRINOX chemotherapy for people with pancreatic cancer that cannot be removed by surgery or has spread to other parts of the body. It aims to see if the new dosing schedule works better and is safe.
Hear when a new Small Bowel Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.